Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amyloidosis Transthyretin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05758493
What this trial is testing

Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

Who this might be right for
AmyloidosisTransthyretin Amyloidosis
Oregon Health and Science University 150
Large-scale testing (Phase 3)Study completedNCT03862807
What this trial is testing

Patisiran in Patients With Hereditary Transthyretin-mediated Amyloidosis (hATTR Amyloidosis) Disease Progression Post-Liver Transplant

Who this might be right for
Amyloidosis, FamilialTransthyretin Amyloidosis
Alnylam Pharmaceuticals 24
Not applicableLooking for participantsNCT07690436
What this trial is testing

Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
AstraZeneca 500
Post-approval studies (Phase 4)Study completedNCT05233163
What this trial is testing

SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy

Who this might be right for
Transthyretin Amyloid Cardiomyopathy
Columbia University 15
Large-scale testing (Phase 3)Study completedNCT03860935
What this trial is testing

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Who this might be right for
AmyloidosisAmyloid CardiomyopathyTransthyretin Amyloidosis+2 more
Eidos Therapeutics, a BridgeBio company 632
Not applicableNot Yet RecruitingNCT06921408
What this trial is testing

Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)

Who this might be right for
Cardiac AmyloidosisTransthyretin Amyloidosis
University Hospital, Lille 57
Not applicableUnknownNCT06345235
What this trial is testing

New Biomarkers and Plasma Prothrombotic Potential in Cardiac Transthyretin Amyloidosis

Who this might be right for
Transthyretin Amyloidosis
John Paul II Hospital, Krakow 100
Large-scale testing (Phase 3)Study completedNCT04136184
What this trial is testing

NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Who this might be right for
Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Ionis Pharmaceuticals, Inc. 168
Large-scale testing (Phase 3)Study completedNCT00409175
What this trial is testing

Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis

Who this might be right for
Familial Amyloid Polyneuropathy
Pfizer 128
Large-scale testing (Phase 3)Study completedNCT04298372
What this trial is testing

Frontline Lenalidomide for AL Amyloidosis Involving Myocardium

Who this might be right for
Amyloidosis Cardiac
Seoul National University Hospital 2
Large-scale testing (Phase 3)Study completedNCT05064839
What this trial is testing

Imaging for the Evaluation of Transthyretin Cardiac Amyloidosis Prevalence of Patients Over 65 Hospitalized in Cardiology Wards (the IMPACT Study)

Who this might be right for
Transthyretin Cardiac Amyloidosis
Poitiers University Hospital 553
Not applicableStudy completedNCT04242667
What this trial is testing

Penn Biobank Return of Research Results Program

Who this might be right for
CancerCardiovascular DiseasesHereditary Cancer+1 more
Abramson Cancer Center at Penn Medicine 260
Not applicableLooking for participantsNCT05950867
What this trial is testing

Prevalence of Wild-type TTR Cardiac Amyloidosis in Patients With Polyneuropathy of Unknown Cause.

Who this might be right for
PolyneuropathyAmyloidosis
Universitair Ziekenhuis Brussel 150
Not applicableLooking for participantsNCT06291805
What this trial is testing

Phenotyping and Characterization of wtATTR-CM (TRACE 1)

Who this might be right for
Transthyretin AmyloidosisTransthyretin Amyloid CardiomyopathyWild-Type Transthyretin-Related (ATTR)Amyloidosis+1 more
Steen Hvitfeldt Poulsen 120
Post-approval studies (Phase 4)Study completedNCT04828993
What this trial is testing

The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients

Who this might be right for
Transthyretin Amyloid Polyneuropathy (ATTR-PN)
Pfizer 15
Large-scale testing (Phase 3)Study completedNCT01435655
What this trial is testing

The Effect Of Tafamidis For The Transthyretin Amyloid Polyneuropathy Patients With V30M Or Non-V30M Transthyretin

Who this might be right for
Transthyretin Familial Amyloid Polyneuropathy
Pfizer 10
Not applicableNot Yet RecruitingNCT07170306
What this trial is testing

Cardiac Amyloidosis in Patients With Aortic Stenosis

Who this might be right for
Aortic StenosisTransthyretin Amyloid Cardiomyopathy
Shanghai Zhongshan Hospital 143
Early research (Phase 1)Study completedNCT05201911
What this trial is testing

Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis

Who this might be right for
Amyloidosis; Systemic
Attralus, Inc. 13
Not applicableStudy completedNCT03190577
What this trial is testing

Assessment of the Prevalence of TTR Amyloid Neuropathy in a Population of Patients With Neuropathy of Unknown Aetiology

Who this might be right for
Familial Amyloid NeuropathyTransthyretin Amyloidosis
Nantes University Hospital 400
Not applicableActive Not RecruitingNCT07338942
What this trial is testing

Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Populations

Who this might be right for
ATTR-CM
AstraZeneca 4,000
Next Page